Get my own profile
Public access
View all28 articles
6 articles
available
not available
Based on funding mandates
Co-authors
- Marwin SeglerMicrosoft Research AI for ScienceVerified email at microsoft.com
- Peter ErtlLeading Scientist at Ertl MolecularVerified email at peter-ertl.com
- Joshua MeyersProtein Engineering AI Lead, Synteny BiotechnologyVerified email at synteny.ai
- Sarah R. LangdonPhD Student, The Institute of Cancer ResearchVerified email at icr.ac.uk
- Paul WorkmanChief Executive & President, Institute of Cancer Research, LondonVerified email at icr.ac.uk
- Richard BaylissProfessor, University of LeedsVerified email at leeds.ac.uk
- Yi MokBenevolentAIVerified email at benevolent.ai
- Lewis R. VidlerComputational Medicinal Chemist, Eli Lilly and CompanyVerified email at lilly.com
- Stefan KnappUniversity of FrankfurtVerified email at pharmchem.uni-frankfurt.de
- Nicholas FirthVerified email at ucl.ac.uk
- Richard A. LewisNovartis, BaselVerified email at novartis.com
- Christos A NicolaouSenior Scientific Director, Computational Drug Discovery, Novo NordiskVerified email at novonordisk.com
- Isaac WestwoodThe Institute of Cancer ResearchVerified email at icr.ac.uk
- Jeremy L. JenkinsUS Head Discovery Sciences, Novartis BioMedical ResearchVerified email at novartis.com
- Oleg FedorovUniversity of OxfordVerified email at cmd.ox.ac.uk
- Panagis FilippakopoulosAssociate Professor, Oxford UniversityVerified email at sgc.ox.ac.uk
- Fabio BroccatelliDirector at Altos LabsVerified email at altoslabs.com
- George PapadatosHead of Data, Syngenta CP R&DVerified email at syngenta.com
- Ruth BrenkUniversity of BergenVerified email at uib.no
- Pascal FuretDirector and leading scientist at NovartisVerified email at novartis.com